Abstract
A concurrent superselective intra-arterial chemoradiotherapy (SIACRT) is a new therapeutic strategy for advanced squamous cell carcinomas of the maxillary sinus and upper gingiva that might enable patients to keep the shape and function as well as improve curability. We have been applying SIACRT since 2008. We will present the results of SIACRT compared to conventional combined therapy at our hospital. SIACRT is promising to preserve patient’s quality of life (QOL) both under and after the treatment without sacrificing a cure rate.
Keywords: Cisplatin, Head and neck cancer, Superselective intra-arterial chemoradiotherapy, 5-Fluorouracil.
Related Journals
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents